针对的修改的阿特金斯饮食:二十年的"替代"性饮食治疗方法
1Departments of Neurology and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland.
修改的阿特金斯饮食 (Modified Atkins Diet) 是一种治疗的性饮食疗法,在过去的20年里,它从一系列病例发展成为青少年和成年人的经过验证的门诊治疗方法,目前正在对新发和其他神经疾病进行研究.
科学领域:
- 神经学 神经学
- 营养科学 营养科学
- 饮食疗法是一种饮食疗法.
背景情况:
- 修改后的阿特金斯饮食 (MAD) 于2003年出现,作为一种简化的性治疗方法.
- 最初是一个案例系列,MAD已经经历了广泛的研究,包括随机对照试验,超过二十年.
研究的目的:
- 为了回顾20年的历史,临床证据和修改的阿特金斯饮食治疗的未来方向.
- 突出MAD作为神经疾病的显著基饮食疗法选择.
主要方法:
- 发表文献的审查,包括关于修改的阿特金斯饮食的病例系列和随机对照试验.
- 与经典饮食相比,对饮食的实施,有效性和不良影响的分析.
主要成果:
- 修改的阿特金斯饮食被确立为一种经过验证的类食疗法,用于治疗,特别是在青少年和成人中.
- 研究表明,MAD在新发和其他神经系统疾病中具有潜在的潜力,可能比传统的性饮食产生更少的不良影响.
结论:
- 修改后的阿特金斯饮食代表了过去20年症食疗法的成功演变.
- MAD是一种有价值的治疗选择,在神经病学中应用范围不断扩大.
更多相关视频
07:01Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
05:42Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
Published on: January 7, 2019
相关概念视频
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Arteries of the Lower Limbs
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
